» Articles » PMID: 3342669

Evaluation of Clinical Methods for Rating Dyspnea

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 1988 Mar 1
PMID 3342669
Citations 632
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate available clinical methods (self ratings and questionnaire) for rating dyspnea, we (1) compared scores from the recently developed baseline dyspnea index (BDI) with the Medical Research Council (MRC) scale and the oxygen-cost diagram (OCD) in 153 patients with various respiratory diseases who sought medical care for shortness of breath; and (2) evaluated the relationships between dyspnea scores and standard measures of physiologic lung function in the same patients. The dyspnea scores were all significantly correlated (r = 0.48 to 0.70; p less than 0.001). Agreement between two observers or with repeated use was satisfactory with all three clinical rating methods. The BDI showed the highest correlations with physiologic measurements. Dyspnea scores were most highly related to spirometric values (r = 0.78; p less than 0.001) for patients with asthma, maximal respiratory pressures (r = 0.34 and 0.35; p less than 0.001) for patients with chronic obstructive pulmonary disease, and PImax (r = 0.51; p = 0.01) and FVC (r = 0.44; p = 0.03) for those with interstitial lung disease. These results show that: (1) the BDI, MRC scale, and OCD provide significantly related measures of dyspnea; (2) the clinical ratings of dyspnea correlate significantly with physiologic parameters of lung function; and (3) breathlessness may be related to the pathophysiology of the specific respiratory disease. The clinical rating of dyspnea may provide quantitative information complementary to measurements of lung function.

Citing Articles

Progression in Fibrotic Interstitial Lung Diseases: Prevalence and Indicators in the Initial Evaluation in a Brazilian Multicentric Cohort.

Resende A, Cordero S, Mancuzo E, Storrer K, Moreira M, Baptista F Cureus. 2025; 17(3):e80290.

PMID: 40066320 PMC: 11892080. DOI: 10.7759/cureus.80290.


The Canadian Lung Outcomes in Users of Vaping Devices (CLOUD) Study: protocol for a prospective, observational cohort study.

Burns P, Eddy R, Li X, Yang J, Dhillon S, Couillard S BMJ Open. 2025; 15(3):e100568.

PMID: 40050062 PMC: 11887296. DOI: 10.1136/bmjopen-2025-100568.


The effectiveness of functional inspiratory muscle training on exercise capacity and peripheral muscle strength in patients with essential hypertension: a three-arm randomized controlled trial.

Huzmeli I, Katayifci N, Abay B, Akkus O, Ozer A BMC Sports Sci Med Rehabil. 2025; 17(1):29.

PMID: 40022256 PMC: 11869749. DOI: 10.1186/s13102-025-01082-w.


Outcomes from the Victorian Healthy Homes Program: a randomised control trial of home energy upgrades.

Page K, Hossain L, Liu D, Kim Y, Wilmot K, Kenny P BMJ Open. 2025; 15(2):e082340.

PMID: 40010814 PMC: 11865758. DOI: 10.1136/bmjopen-2023-082340.


Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge.

Toufen Jr C, de Almeida G, Pompeu J, de Carvalho C, de Carvalho C Sci Rep. 2025; 15(1):6744.

PMID: 40000709 PMC: 11862020. DOI: 10.1038/s41598-025-91010-2.